Effects of interferon on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients

Hepatology

Volumn 26, Issue 3, 1997, Pages 792-797

  Missale, Gabriele ^a   Cariani, Elisabetta ^b   Lamonaca, Vincenzo ^a   Ravaggi, Antonella ^b   Rossini, Angelo ^c   Bertoni, Roberto ^a   Houghton, Michael ^d   Matsuura, Yoshiharu ^e   Miyamura, Tatsuo ^e   Fiaccadori, Franco ^a   Ferrari, Carlo ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c SPEDALI CIVILI   (Italy)

^d NOVARTIS PHARMA AG   (Switzerland)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; CORE PROTEIN; HEPATITIS C ANTIBODY; PRIMER DNA; RECOMBINANT INTERFERON; VIRUS RNA;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION; VIRUS TYPING; ADULT; BLOOD; CELLULAR IMMUNITY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HEPATITIS C; IMMUNOLOGY; MIDDLE AGED; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VIROLOGY;

ADULT; AMINO ACID SEQUENCE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RNA, VIRAL; T-LYMPHOCYTES; VIRAL CORE PROTEINS;

EID: 0031230799     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260337     Document Type: Article

References (27)

1. Alter HJ. To C or not to C: these are the questions. Blood 1995;85: 1681-1695.
2. Conjeevaram SH, Everhart EJ, Hoofnagle HJ. Predictors of a sustained beneficial response to interferon alfa therapy in cronic hepatitis C. HEPATOLOGY 1995;22:1326-1329.
3. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977;74:5463-5467.
4. Ravaggi A, Zonaro A, Mazza C, Albertini A, Cariani E. Quantification of hepatitis C virus RNA by competitive amplification of RNA from denatured serum and hybridization on microliter plates. J Clin Micro-biol 1995;33:265-269.
5. Choo Q-L, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991;88:2451-2455.
6. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Guiberti T, Schianchi C, et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. HEPATOLOGY 1994;19:286-295.
7. Kakimi K, Kuribayashi K, Iwashiro M, Masuda T, Sakai M, Ling W, Kubo Y, et al. Hepatitis C virus core region: helper T cell epitopes recognized by BALB/c and C57BL/6 mice. J Gen Virol 1995;76:1205-1214.
8. Saxon A, Feldbaus J, Robins RA. Single step separation of human T and B cells using AET-treated sheep red cells. J Immunol Methods 1976; 12:285-290.
9. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996;98:706-714.
10. Diepolder HM, Zachoval R, Hoffman RM, Wierenga EA, Santantonio T, Jung M-C, Eichenlaub D, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995;346:1006-1007.
11. Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Annu Rev Biochem 1987;56:727-777.
12. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. HEPATOLOGY 1995;21: 285-290.
13. Alcami A, Smith GL. Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol Today 1995;16:474-478.
14. Hsu DH, de Waal Malefyt R, Fiorentino F, Dang MN, Vieira P, deVries J, Spits H, et al. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 1996;250:830-832.
15. Rager-Zisman B, Ju G, Rajan TV, Bloom BR. Decreased expresssion of H-2 antigens following acute measles virus infection. Cell Immunol 1981;59:319-329.
16. Schrier PI, Bernards R, Vaessen RTMJ HA, Van der Eb AJ. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 1983;305:771-775.
17. Nilsson T, Jackson M, Peterson PA. Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 1989;58:707-718.
18. Gabathuler R, Levy F, Kvist S. Requirements for the association of adenovirus type 2 E3/19K wild type and mutant proteins with HLA antigens. J Virol 1990;64:3679-3685.
19. Browne H, Smith G, Beck S, Minson T. A complex between the MHC class I homologue encoded by human cytomegalovirus and b2 microglobulin. Nature 1990;347:770-772.
20. Oldstone MBA. Viral persistence. Cell 1989;56:517-520.
21. Fruh K, Ahn K, Djaballah H, Sempä P, van Endert PM, TampÄ R, Peterson PA, et al. A viral inhibitor of peptide transporters for antigen presentation. Nature 1995;375:415-418.
22. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995;375:411-415.
23. Chemello L, Bonetti P, Cavalletto L, Talato F, Donadon V, Casarin P, Belussi F, et al. Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group. HEPATOLOGY 1995;22:700-706.
24. Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, Zauli D, et al. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. J Clin Invest 1995;95:2067-2075.
25. Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol 1992;66:1476-1483.
26. Matsumoto M, Zhu N, Hwang SB, Su PY, van Arsdale T, Ware FC, Lai M. Interactions of hepatitis C virus core protein with member of tumor necrosis factor receptor family: implications for HCV persistency and pathogenesis [Abstract]. Third International Meeting on HCV and Related Viruses. 1995;August 30-September 3:C48.
27. Bukh J, Purcell RH, Miller RH. Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci U S A 1994;91:8239-8243.